Corient Capital Partners’s Chemed CHE Stock Holding History

Corient Capital Partners’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$347K	Buy	739 +225	+44%	+$108K	0.03%	421
2022 Q2	$241K	Sell	514 -238	-32%	-$116K	0.02%	554
2022 Q1	$381K	Buy	752 +238	+46%	+$114K	0.03%	453
2021 Q4	$272K	Hold	514	–	–	0.02%	558
2021 Q3	$239K	Sell	514 -213	-29%	-$100K	0.02%	574
2021 Q2	$345K	Hold	727	–	–	0.03%	454
2021 Q1	$334K	Buy	727 +3	+0.4%	+$1.47K	0.03%	420
2020 Q4	$386K	Buy	724 +170	+31%	+$83.5K	0.04%	325
2020 Q3	$266K	Hold	554	–	–	0.03%	366
2020 Q2	$250K	Sell	554 -53	-9%	-$23.7K	0.03%	381
2020 Q1	$263K	Hold	607	–	–	0.04%	316
2019 Q4	$267K	Buy	607 +82	+16%	+$34.5K	0.03%	381
2019 Q3	$219K	Buy	+525	New	+$214K	0.03%	389

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Corient Capital Partners's CHE Position: Q3 2022 in Review

Corient Capital Partners increased its Chemed (CHE) stake by 44% in Q3 2022, buying an estimated $108K and bringing the position to 739 shares worth $347K. The position accounts for 0.03% of the portfolio, ranked #421.

Corient Capital Partners first reported a position in CHE in Q3 2019 and has held it in 13 quarters since. The position peaked at $386K in Q4 2020. 419 funds tracked by Wall St. Rank hold CHE as of Q3 2022.

Corient Capital Partners held 739 shares of Chemed worth $347K as of Q3 2022.
Corient Capital Partners bought 225 Chemed shares in Q3 2022, an estimated $108K.
Chemed made up 0.03% of Corient Capital Partners's portfolio in Q3 2022, its #421 holding.
Corient Capital Partners first reported a position in Chemed in Q3 2019 and has held it in 13 quarters since.
Corient Capital Partners's Chemed position peaked at $386K in Q4 2020.
419 funds tracked by Wall St. Rank held Chemed as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.